FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3099682853> ?p ?o ?g. }

• W3099682853 endingPage "846" @default.
• W3099682853 startingPage "834" @default.
• W3099682853 abstract "Abstract Hypomethylating agents (HMA) have become the backbone of nonintensive acute myeloid leukemia/myelodysplastic syndrome (AML/MDS) treatment, also by virtue of their activity in patients with adverse genetics, for example, monosomal karyotypes, often with losses on chromosome 7, 5, or 17. No comparable activity is observed with cytarabine, a cytidine analogue without DNA-hypomethylating properties. As evidence exists for compounding hypermethylation and gene silencing of hemizygous tumor suppressor genes (TSG), we thus hypothesized that this effect may preferentially be reversed by the HMAs decitabine and azacitidine. An unbiased RNA-sequencing approach was developed to interrogate decitabine-induced transcriptome changes in AML cell lines with or without a deletion of chromosomes 7q, 5q or 17p. HMA treatment preferentially upregulated several hemizygous TSG in this genomic region, significantly derepressing endogenous retrovirus (ERV)3–1, with promoter demethylation, enhanced chromatin accessibility, and increased H3K4me3 levels. Decitabine globally reactivated multiple transposable elements, with activation of the dsRNA sensor RIG-I and interferon regulatory factor (IRF)7. Induction of ERV3–1 and RIG-I mRNA was also observed during decitabine treatment in vivo in serially sorted peripheral blood AML blasts. In patient-derived monosomal karyotype AML murine xenografts, decitabine treatment resulted in superior survival rates compared with cytarabine. Collectively, these data demonstrate preferential gene derepression and ERV reactivation in AML with chromosomal deletions, providing a mechanistic explanation that supports the clinical observation of superiority of HMA over cytarabine in this difficult-to-treat patient group. Significance: These findings unravel the molecular mechanism underlying the intriguing clinical activity of HMAs in AML/MDS patients with chromosome 7 deletions and other monosomal karyotypes. See related commentary by O'Hagan et al., p. 813" @default.
• W3099682853 created "2020-11-23" @default.
• W3099682853 creator A5006559585 @default.
• W3099682853 creator A5009884702 @default.
• W3099682853 creator A5011506972 @default.
• W3099682853 creator A5013991182 @default.
• W3099682853 creator A5019540447 @default.
• W3099682853 creator A5020136143 @default.
• W3099682853 creator A5027995282 @default.
• W3099682853 creator A5032050718 @default.
• W3099682853 creator A5034493142 @default.
• W3099682853 creator A5044022855 @default.
• W3099682853 creator A5047951694 @default.
• W3099682853 creator A5053018037 @default.
• W3099682853 creator A5069804905 @default.
• W3099682853 creator A5080865036 @default.
• W3099682853 creator A5090227548 @default.
• W3099682853 date "2021-02-15" @default.
• W3099682853 modified "2023-10-17" @default.
• W3099682853 title "Decitabine Induces Gene Derepression on Monosomic Chromosomes: <i>In Vitro</i> and <i>In Vivo</i> Effects in Adverse-Risk Cytogenetics AML" @default.
• W3099682853 cites W1515776555 @default.
• W3099682853 cites W1600365609 @default.
• W3099682853 cites W1905278501 @default.
• W3099682853 cites W1953890763 @default.
• W3099682853 cites W1991858306 @default.
• W3099682853 cites W1992275707 @default.
• W3099682853 cites W1995940145 @default.
• W3099682853 cites W1996919750 @default.
• W3099682853 cites W2006559366 @default.
• W3099682853 cites W2017421515 @default.
• W3099682853 cites W2022572639 @default.
• W3099682853 cites W2046766666 @default.
• W3099682853 cites W2050736448 @default.
• W3099682853 cites W2061177157 @default.
• W3099682853 cites W2066302281 @default.
• W3099682853 cites W2074191990 @default.
• W3099682853 cites W2096652998 @default.
• W3099682853 cites W2098362718 @default.
• W3099682853 cites W2102899429 @default.
• W3099682853 cites W2106084333 @default.
• W3099682853 cites W2106833395 @default.
• W3099682853 cites W2109895173 @default.
• W3099682853 cites W2115102290 @default.
• W3099682853 cites W2117086969 @default.
• W3099682853 cites W2128287324 @default.
• W3099682853 cites W2134526812 @default.
• W3099682853 cites W2140729960 @default.
• W3099682853 cites W2155249898 @default.
• W3099682853 cites W2179438025 @default.
• W3099682853 cites W2259938310 @default.
• W3099682853 cites W2341539131 @default.
• W3099682853 cites W2346143774 @default.
• W3099682853 cites W2419140434 @default.
• W3099682853 cites W2549790759 @default.
• W3099682853 cites W2575307244 @default.
• W3099682853 cites W2625655191 @default.
• W3099682853 cites W2750416916 @default.
• W3099682853 cites W2760824708 @default.
• W3099682853 cites W2783347513 @default.
• W3099682853 cites W2801884851 @default.
• W3099682853 cites W2892949113 @default.
• W3099682853 cites W2901949277 @default.
• W3099682853 cites W2918119545 @default.
• W3099682853 cites W2928665623 @default.
• W3099682853 cites W2992296498 @default.
• W3099682853 cites W3014592612 @default.
• W3099682853 cites W3025149552 @default.
• W3099682853 cites W3026659889 @default.
• W3099682853 cites W3048827006 @default.
• W3099682853 doi "https://doi.org/10.1158/0008-5472.can-20-1430" @default.
• W3099682853 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33203699" @default.
• W3099682853 hasPublicationYear "2021" @default.
• W3099682853 type Work @default.
• W3099682853 sameAs 3099682853 @default.
• W3099682853 citedByCount "16" @default.
• W3099682853 countsByYear W30996828532021 @default.
• W3099682853 countsByYear W30996828532022 @default.
• W3099682853 countsByYear W30996828532023 @default.
• W3099682853 crossrefType "journal-article" @default.
• W3099682853 hasAuthorship W3099682853A5006559585 @default.
• W3099682853 hasAuthorship W3099682853A5009884702 @default.
• W3099682853 hasAuthorship W3099682853A5011506972 @default.
• W3099682853 hasAuthorship W3099682853A5013991182 @default.
• W3099682853 hasAuthorship W3099682853A5019540447 @default.
• W3099682853 hasAuthorship W3099682853A5020136143 @default.
• W3099682853 hasAuthorship W3099682853A5027995282 @default.
• W3099682853 hasAuthorship W3099682853A5032050718 @default.
• W3099682853 hasAuthorship W3099682853A5034493142 @default.
• W3099682853 hasAuthorship W3099682853A5044022855 @default.
• W3099682853 hasAuthorship W3099682853A5047951694 @default.
• W3099682853 hasAuthorship W3099682853A5053018037 @default.
• W3099682853 hasAuthorship W3099682853A5069804905 @default.
• W3099682853 hasAuthorship W3099682853A5080865036 @default.
• W3099682853 hasAuthorship W3099682853A5090227548 @default.
• W3099682853 hasBestOaLocation W30996828531 @default.
• W3099682853 hasConcept C104317684 @default.
• W3099682853 hasConcept C150194340 @default.
• W3099682853 hasConcept C186310378 @default.

• next